| Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors (NCT06439589) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-06-12 |
| The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer (NCT05422690) | Inova Health Care Services | 2024-06-12 |
| Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors (NCT06239194) | ModeX Therapeutics, An OPKO Health Company | 2024-06-12 |
| Efficacy and Safety of SPC1001 in Patients With Essential Hypertension (NCT06826872) | Shin Poong Pharmaceutical Co. Ltd. | 2024-06-12 |
| FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC (NCT06303505) | Tubulis GmbH | 2024-06-12 |
| AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy (NCT06063850) | UniQure Biopharma B.V. | 2024-06-12 |
| A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors (NCT06480240) | OBI Pharma, Inc | 2024-06-12 |
| DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia (NCT06382168) | Delta-Fly Pharma, Inc. | 2024-06-12 |
| ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments (NCT06429059) | Duke University | 2024-06-12 |
| Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma (NCT06252675) | University of California, San Francisco | 2024-06-11 |
| Immunotherapy in Eyelid Viral Papilloma (NCT06720467) | Zagazig University | 2024-06-11 |
| A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) (NCT06285643) | AskBio Inc | 2024-06-11 |
| Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) (NCT06467344) | Ascidian Therapeutics, Inc | 2024-06-11 |
| Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (NCT06336642) | M.D. Anderson Cancer Center | 2024-06-11 |
| Nightmare Deconstruction and Reprocessing vs. NightWare Wristband (NCT06399874) | Uniformed Services University of the Health Sciences | 2024-06-11 |
| Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01) (NCT06611813) | First Affiliated Hospital of Zhejiang University | 2024-06-11 |
| A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms (NCT06398444) | Sinotau Pharmaceutical Group | 2024-06-11 |
| Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells (NCT06491043) | Meribank Biotech Co., Ltd. | 2024-06-11 |
| Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment (NCT06106802) | Samsung Medical Center | 2024-06-11 |
| Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis (NCT05815797) | Chinese University of Hong Kong | 2024-06-11 |
| Study on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 70 Years Old (NCT06652906) | RenJi Hospital | 2024-06-11 |
| App for Reducing Cravings to Smoke (NCT06088498) | H. Lee Moffitt Cancer Center and Research Institute | 2024-06-11 |
| Study of ALTO-101 in Patients With Schizophrenia (NCT06502964) | Alto Neuroscience | 2024-06-11 |
| Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers (NCT05919108) | Vanderbilt-Ingram Cancer Center | 2024-06-11 |
| Rationale and Design of Diabetes Management With Curcumin and Saffron (DMCS): a Randomised, Three Blind -Blind, Placebo-controlled Study (NCT06413238) | Fateme Moshirenia | 2024-06-10 |
| Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty (NCT06479161) | Matthew Grosso, MD | 2024-06-10 |
| Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder (NCT06384157) | Indivior Inc. | 2024-06-10 |
| IVIG for Infection Prevention After CAR-T-Cell Therapy (NCT05952804) | Fred Hutchinson Cancer Center | 2024-06-10 |
| Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer (NCT06426654) | West China Hospital | 2024-06-10 |
| Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer (NCT06223568) | National Cancer Institute (NCI) | 2024-06-10 |
| Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease (NCT07298343) | Dr. Falk Pharma GmbH | 2024-06-10 |
| Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT (NCT06482801) | Second Affiliated Hospital of Guangzhou Medical University | 2024-06-10 |
| A Study of IVX-A12 in Adults Participants (NCT06481579) | Icosavax, Inc. | 2024-06-10 |
| Intra-articular Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint (NCT06459063) | Kaplan Medical Center | 2024-06-10 |
| A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension (NCT06336356) | AstraZeneca | 2024-06-10 |
| Lysergic Acid Diethylamide (LSD) in Palliative Care (NCT05883540) | University Hospital, Basel, Switzerland | 2024-06-09 |
| Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis (NCT06976177) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2024-06-07 |
| Brigatinib Post Definitive Chemo-radiotherapy in Patients with ALK-fusion Non-small Cell Lung Cancer (NCT05718297) | ETOP IBCSG Partners Foundation | 2024-06-07 |
| Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT06082167) | Exelixis | 2024-06-07 |
| The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study (NCT05538208) | Children's Hospital Medical Center, Cincinnati | 2024-06-07 |
| Wereables for Upper Limb Functionality in Hemiparesis (NCT06872736) | Universidade da Coruña | 2024-06-07 |
| A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors (NCT06437522) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-06-07 |
| The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial (NCT06050577) | Odense University Hospital | 2024-06-07 |
| Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma (NCT06885814) | Nanfang Hospital, Southern Medical University | 2024-06-06 |
| Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer (NCT06416085) | University Health Network, Toronto | 2024-06-06 |
| The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence (NCT05814055) | University of Florida | 2024-06-06 |
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata (NCT06444451) | Sanofi | 2024-06-06 |
| Comparison of Rimegepant and Placebo for Pain in IBS (NCT06221111) | Mayo Clinic | 2024-06-06 |
| Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal (NCT05501470) | Institut Pasteur de Dakar | 2024-06-06 |
| Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen (NCT06456892) | Sun Yat-sen University | 2024-06-06 |
| A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B (NCT06425341) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-06-06 |
| A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP) (NCT06367972) | M.D. Anderson Cancer Center | 2024-06-06 |
| Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. (NCT06163573) | University Hospital, Basel, Switzerland | 2024-06-06 |
| A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1) (NCT06277219) | Latticon Antibody Therapeutics, Inc | 2024-06-05 |
| The Effect of GD-iExo-003 in Acute Ischemic Stroke (NCT06138210) | Xuanwu Hospital, Beijing | 2024-06-05 |
| Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer (NCT06475326) | Fudan University | 2024-06-05 |
| Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease (NCT06270316) | UniQure Biopharma B.V. | 2024-06-05 |
| MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. (NCT06412497) | Masonic Cancer Center, University of Minnesota | 2024-06-05 |
| Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma (NCT06528847) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-06-05 |
| Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. (NCT06447506) | GlaxoSmithKline | 2024-06-05 |
| Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis (NCT06097832) | Nexcella Inc. | 2024-06-05 |
| Vasodilator and Exercise Study for DMD (VASO-REx) (NCT06290713) | University of Florida | 2024-06-05 |
| A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension (NCT06423352) | Alnylam Pharmaceuticals | 2024-06-05 |
| Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer (NCT06458413) | Min Yan, MD | 2024-06-05 |
| T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases (NCT06048718) | MedSIR | 2024-06-05 |
| Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer (NCT06434090) | Sun Yat-sen University | 2024-06-05 |
| Delayed Cold-Stored Platelets -PLTS-1 (NCT06147531) | University Health Network, Toronto | 2024-06-05 |
| Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC (NCT06184399) | Jennifer Keiser | 2024-06-05 |
| Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA (NCT06393452) | Pelage Pharmaceuticals, Inc. | 2024-06-05 |
| Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer (NCT06413745) | Jiangsu HengRui Medicine Co., Ltd. | 2024-06-04 |
| Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC (NCT06064279) | VA Office of Research and Development | 2024-06-04 |
| Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma (NCT06192797) | Tongji Hospital | 2024-06-04 |
| A Clinical Study of YL205 in Patients With Advanced Solid Tumors (NCT06459973) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2024-06-04 |
| Regenerative Treatment of Female Genital Atrophy (NCT07306611) | AndreiaAntunes | 2024-06-04 |
| Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. (NCT06394232) | Eyestem Research Pvt. Ltd. | 2024-06-04 |
| A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes (NCT06229912) | M.D. Anderson Cancer Center | 2024-06-04 |
| A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer (NCT06457919) | Memorial Sloan Kettering Cancer Center | 2024-06-04 |
| A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure (NCT06299826) | AstraZeneca | 2024-06-04 |
| Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 (NCT06283459) | Imunon | 2024-06-04 |
| Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients (NCT06389695) | Norroy Bioscience Co., LTD | 2024-06-04 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. (NCT06493578) | Vyne Therapeutics Inc. | 2024-06-04 |
| Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy (NCT06490068) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-06-04 |
| Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis. (NCT06364176) | University of Kansas Medical Center | 2024-06-03 |
| Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF (NCT06468527) | Kors van der Ent | 2024-06-03 |
| A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form (NCT06540352) | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 2024-06-03 |
| Mesenchymal Stem Cells for Frailty Syndrome (NCT06501066) | Meribank Biotech Co., Ltd. | 2024-06-03 |
| A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia (NCT05780879) | University of Michigan Rogel Cancer Center | 2024-06-03 |
| Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial (NCT06378866) | Mayo Clinic | 2024-06-03 |
| Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. (NCT06640166) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2024-06-03 |
| Postbiotic as Adjunct Treatment for Vaginal Candidiasis (NCT06474247) | Min-Tze LIONG | 2024-06-02 |
| Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide (NCT06430489) | University Hospital, Tours | 2024-06-01 |
| The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis (NCT06470386) | Shanghai Changzheng Hospital | 2024-06-01 |
| Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment (NCT06445881) | First Affiliated Hospital of Zhejiang University | 2024-06-01 |
| Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders (NCT05909943) | Tianjin Medical University General Hospital | 2024-06-01 |
| Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial. (NCT06426056) | Peking University Third Hospital | 2024-06-01 |
| PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients (NCT06359275) | Fudan University | 2024-06-01 |
| Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC (NCT06465238) | Henan Cancer Hospital | 2024-06-01 |
| METFORMIN FOR ATRIAL FIBRILLATION (NCT05878535) | Arab Contractors Medical Centre | 2024-06-01 |
| Dexmedetomidine and Vasopressin in Septic Shock (NCT06302998) | Mansoura University | 2024-06-01 |
| CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma (NCT06433362) | Tianjin Medical University Cancer Institute and Hospital | 2024-06-01 |